Heart transplantation from donation after circulatory death (DCD) donors is a rapidly
expanding practice. In this review, we describe the history and challenges of DCD heart …

Cardiac transplantation has become limited by a critical shortage of suitable organs from
brain-dead donors. Reports describing the successful clinical transplantation of hearts …

BACKGROUND In an effort to address the increasing demand for heart transplantation
within the United Kingdom (UK), we established a clinical program of heart transplantation …

Extracorporeal circulation (ECC) systems, including cardiopulmonary bypass, and
extracorporeal membrane oxygenation have been an irreplaceable part of the …

BACKGROUND Donation after circulatory death (DCD) offers an additional source of
cardiac allografts, potentially allowing expansion of the donor pool, but is limited owing to …

Heart transplantation remains the gold-standard therapy for end-stage heart failure; the
expected median survival range is 12–13 years. More than 30,000 heart transplants have …

An ex vivo heart perfusion device preserves the donor heart in a warm beating state during
transfer between extraction and implantation surgeries. One of the current challenges …

Heart transplantation remains the preferred option for improving quality of life and survival
for patients suffering from end-stage heart failure. Unfortunately, insufficient supply of …

Despite the advancements in medical treatment, mechanical support, and stem cell therapy,
heart transplantation remains the most effective treatment for selected patients with …

Heart transplantation remains the treatment of reference for patients experiencing end‐stage
heart failure; unfortunately, graft availability through conventional donation after brain death …